FOLH1 and posterior cortical atrophy: However, with recent attention on MRI‐invisible but PET‐avid clinically significant PCa22 along with recent retrospective evidence suggesting that PSMA PET/CT in conjunction with MRI and systematic biopsy may improve the detection of clinically significant PCa in those with intermediate risk PCa,23 future efforts should further evaluate whether PSMA PET/CT should become a routine staging procedure for those with intermediate risk PCa, considering FT.